- call +1-201-465-4211
- email sales@mrinsights.biz
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
Scope of the Report:
This report focuses on the Contraceptive Drugs and Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population.
The worldwide market for Contraceptive Drugs and Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Market Segment by Applications, can be divided into
Hospitals
Pharmacies
Others
There are 15 Chapters to deeply display the global Contraceptive Drugs and Devices market.
Chapter 1, to describe Contraceptive Drugs and Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Contraceptive Drugs and Devices, with sales, revenue, and price of Contraceptive Drugs and Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Contraceptive Drugs and Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Contraceptive Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Contraceptive Drugs and Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Contraceptive Drugs and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Vaginal
1.2.3 Injectable Contraceptive Drugs
1.2.4 Male/Female Contraceptive Devices
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Pharmacies
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer Healthcare
2.1.1 Business Overview
2.1.2 Contraceptive Drugs and Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Contraceptive Drugs and Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Church & Dwight
2.3.1 Business Overview
2.3.2 Contraceptive Drugs and Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Warmer Chilcott
2.4.1 Business Overview
2.4.2 Contraceptive Drugs and Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Agile Therapeutics
2.5.1 Business Overview
2.5.2 Contraceptive Drugs and Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Contraceptive Drugs and Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 BioSante Pharmaceuticals
2.7.1 Business Overview
2.7.2 Contraceptive Drugs and Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mayer Laboratories
2.8.1 Business Overview
2.8.2 Contraceptive Drugs and Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pantarhei Bioscience
2.9.1 Business Overview
2.9.2 Contraceptive Drugs and Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Teva Pharmaceutical Industries
2.10.1 Business Overview
2.10.2 Contraceptive Drugs and Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Contraceptive Drugs and Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Contraceptive Drugs and Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptive Drugs and Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Contraceptive Drugs and Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Contraceptive Drugs and Devices Market Analysis by Regions
4.1 Global Contraceptive Drugs and Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptive Drugs and Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
4.3 Europe Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
4.5 South America Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
5 North America Contraceptive Drugs and Devices by Countries
5.1 North America Contraceptive Drugs and Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Contraceptive Drugs and Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Contraceptive Drugs and Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
5.3 Canada Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
6 Europe Contraceptive Drugs and Devices by Countries
6.1 Europe Contraceptive Drugs and Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Contraceptive Drugs and Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Contraceptive Drugs and Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
6.3 UK Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
6.4 France Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
6.5 Russia Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
6.6 Italy Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Contraceptive Drugs and Devices by Countries
7.1 Asia-Pacific Contraceptive Drugs and Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Contraceptive Drugs and Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Contraceptive Drugs and Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
7.3 Japan Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
7.4 Korea Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
7.5 India Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
8 South America Contraceptive Drugs and Devices by Countries
8.1 South America Contraceptive Drugs and Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Contraceptive Drugs and Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Contraceptive Drugs and Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Contraceptive Drugs and Devices by Countries
9.1 Middle East and Africa Contraceptive Drugs and Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
9.3 UAE Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Contraceptive Drugs and Devices Sales and Growth Rate (2013-2018)
10 Global Contraceptive Drugs and Devices Market Segment by Type
10.1 Global Contraceptive Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Contraceptive Drugs and Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Contraceptive Drugs and Devices Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Vaginal Sales Growth and Price
10.3.1 Global Vaginal Sales Growth (2013-2018)
10.3.2 Global Vaginal Price (2013-2018)
10.4 Injectable Contraceptive Drugs Sales Growth and Price
10.4.1 Global Injectable Contraceptive Drugs Sales Growth (2013-2018)
10.4.2 Global Injectable Contraceptive Drugs Price (2013-2018)
10.5 Male/Female Contraceptive Devices Sales Growth and Price
10.5.1 Global Male/Female Contraceptive Devices Sales Growth (2013-2018)
10.5.2 Global Male/Female Contraceptive Devices Price (2013-2018)
11 Global Contraceptive Drugs and Devices Market Segment by Application
11.1 Global Contraceptive Drugs and Devices Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Pharmacies Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.1 Global Contraceptive Drugs and Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Contraceptive Drugs and Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.2.2 Europe Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.2.4 South America Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Contraceptive Drugs and Devices Market Forecast (2018-2023)
12.3 Contraceptive Drugs and Devices Market Forecast by Type (2018-2023)
12.3.1 Global Contraceptive Drugs and Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Contraceptive Drugs and Devices Market Share Forecast by Type (2018-2023)
12.4 Contraceptive Drugs and Devices Market Forecast by Application (2018-2023)
12.4.1 Global Contraceptive Drugs and Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Contraceptive Drugs and Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Contraceptive Drugs and Devices Picture
Table Product Specifications of Contraceptive Drugs and Devices
Figure Global Sales Market Share of Contraceptive Drugs and D
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
